Bayesian Analysis of the Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia Trial.
Pablo ÁvilaAntonio BerruezoJavier Jiménez-CandilLuis TercedorDavid CalvoFernando Arribas-YnsaurriagaJavier Fernández-PortalesJosè Luis MerinoAntonio Hernández-MadridFrancisco Fernández-AvilésAngel ArenalPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
In patients with ischemic cardiomyopathy and VT, catheter ablation as a first-line therapy resulted in a high probability of reducing several clinical outcomes compared to AAD. Our study highlights the value of Bayesian analysis in clinical trials and its potential for guiding treatment decisions.